EPHA2 and cancer: Downregulation of EphA2 or EphB4 using small interfering RNAs (siRNAs) or antisense oligonucleotides has demonstrated significant impact on cancer cell malignancy in culture and has shown efficacy in inhibiting tumor growth in various mouse cancer models [61].